Harvard Bioscience, Inc.
HBIO
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $36.2M
$8.02
▲ +0.25%
P/E
-3.45
Mkt Cap
$36.2M
52-Wk Range
$3.80–$9.40
52-Week Range
$3.80 - $9.40
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 76.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Over 120 years of heritage and brand recognition in life sciences research
- Proprietary technology platforms with multiple recognized brand names
- Established relationships with key pharmaceutical, biotech, and academic institutions
- Diversified product portfolio reducing dependence on single product categories
Bear Case
1 risk
- Above-average volatility (beta 1.5).
Growth
Stable outlook
Increased pharmaceutical R&D spending and drug development pipeline growth
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+33.4% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying HBIO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 11, 2026
Reported EPS of -$0.14 vs -$0.21 consensus (+33.3% surprise). Revenue of $22.7M vs $21.4M expected (+6.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+33.3%
Revenue trend · last 8Q
—
—
-11%
-11%
-6%
-3%
-5%
+11%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$22.0M
$24.6M
$21.8M
$20.4M
$20.6M
$23.7M
$20.8M
$22.7M
Margins · last 8Q
Gross
55.6%
Operating
-4.3%
Profit
-12.8%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Benchmark · Aug 12, 2026
vs Industry
How HBIO stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related